CELCUITY INC. Liabilities Assumed
CELCUITY INC. (CELC) reported Liabilities Assumed of $0 for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-10.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:LiabilitiesAssumed1 · last filed 2021-05-10
- CELCUITY INC. liabilities assumed for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
- CELCUITY INC. liabilities assumed for the quarter ending 2020-12-31 was $16.62K, a 2291.22% increase year-over-year.
- CELCUITY INC. liabilities assumed for the quarter ending 2020-09-30 was $7.71K.
- CELCUITY INC. liabilities assumed for the quarter ending 2020-06-30 was -$14.10K.
- CELCUITY INC. liabilities assumed for fiscal 2020 was $24.33K, a 801.22% increase from fiscal 2019.
- CELCUITY INC. liabilities assumed for fiscal 2019 was $2.70K, a 88.78% decline from fiscal 2018.
- CELCUITY INC. liabilities assumed for fiscal 2018 was $24.05K.
- CELCUITY INC. liabilities assumed for fiscal 2017 was $0.00.
| Period end | Liabilities Assumed 3 month | Liabilities Assumed 6 month | Liabilities Assumed 9 month | Liabilities Assumed 9 month as first filed | Liabilities Assumed 12 month |
|---|---|---|---|---|---|
| 2021-03-31 | $0.00 10-Q · filed 2021-05-10 | $16.62K derived: sum of 2 quarters · filed 2021-05-10 | $24.33K derived: sum of 3 quarters · filed 2021-05-10 | $10.23K derived: sum of 4 quarters · filed 2021-05-10 | |
| 2020-12-31 | $16.62K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | $24.33K derived: sum of 2 quarters · filed 2021-02-16 | $10.23K derived: sum of 3 quarters · filed 2021-02-16 | $24.33K 10-K · filed 2021-02-16 | |
| 2020-09-30 | $7.71K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2020-11-09 | -$6.39K derived: sum of 2 quarters · filed 2020-11-09 | $7.71K 10-Q · filed 2020-11-09 | $8.41K derived: sum of 4 quarters · filed 2021-05-10 | |
| 2020-06-30 | -$14.10K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2020-08-11 | $0.00 10-Q/A · filed 2020-08-11 | $695.00 derived: sum of 3 quarters · filed 2021-05-10 | $695.00 derived: sum of 4 quarters · filed 2021-05-10 | |
| 2020-03-31 | $14.10K 10-Q · filed 2021-05-10 | $14.80K derived: sum of 2 quarters · filed 2021-05-10 | $14.80K derived: sum of 3 quarters · filed 2021-05-10 | -$84.35K derived: sum of 4 quarters · filed 2021-05-10 | |
| 2019-12-31 | $695.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | $695.00 derived: sum of 2 quarters · filed 2021-02-16 | -$98.45K derived: sum of 3 quarters · filed 2021-02-16 | $2.70K 10-K · filed 2021-02-16 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2020-11-09 | -$99.15K derived: sum of 2 quarters · filed 2020-11-09 | $2.00K 10-Q · filed 2020-11-09 | $750.00 10-Q · filed 2019-11-07 | -$75.09K derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | -$99.15K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2020-08-11 | $2.00K 10-Q/A · filed 2020-08-11 | -$75.09K derived: sum of 3 quarters · filed 2020-08-11 | -$38.82K derived: sum of 4 quarters · filed 2020-08-11 | |
| 2019-03-31 | $101.15K 10-Q · filed 2020-05-07 | $24.06K derived: sum of 2 quarters · filed 2020-05-07 | $60.33K derived: sum of 3 quarters · filed 2020-05-07 | $125.21K derived: sum of 4 quarters · filed 2020-05-07 | |
| 2018-12-31 | -$77.10K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | -$40.83K derived: sum of 2 quarters · filed 2020-03-13 | $24.05K derived: sum of 3 quarters · filed 2020-03-13 | $24.05K 10-K · filed 2020-03-13 | |
| 2018-09-30 | $36.27K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $101.15K derived: sum of 2 quarters · filed 2019-11-07 | $101.15K 10-Q · filed 2019-11-07 | $101.15K derived: sum of 4 quarters · filed 2019-11-07 | |
| 2018-06-30 | $64.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $64.88K 10-Q · filed 2019-08-08 | $64.88K derived: sum of 3 quarters · filed 2019-08-08 | $64.88K derived: sum of 4 quarters · filed 2019-08-08 | |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-07 | $0.00 derived: sum of 2 quarters · filed 2019-05-07 | $0.00 derived: sum of 3 quarters · filed 2019-05-07 | ||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $0.00 derived: sum of 2 quarters · filed 2019-03-01 | $0.00 10-K · filed 2019-03-01 | ||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $0.00 10-Q · filed 2018-11-13 | |||
| 2017-06-30 | $0.00 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |